Patients with metastatic prostate cancer living significantly longer
Neighborhoods most affected by racism and COVID-19 pandemic stressors at a greater risk for preterm births, study finds
2 May 2022Opioid overdose death toll has risen more than 5-fold among Indigenous Americans over past decade
2 May 2022Patients with metastatic prostate cancer living significantly longer
Access to therapies approved over the last decade has significantly lengthened median survival times in patients with metastatic hormone-sensitive prostate cancer. That conclusion comes from a large randomized clinical trial that tested a new treatment for these patients.
